Table 2.
MCL in situ with FL.
| Case number | Histology | Immunohistochemistry flow cytometry |
FISH/southern blot/PCR | Tissue microdissection | Molecular technique to determine clonal relationships | Results interpretation | Ref |
|---|---|---|---|---|---|---|---|
| 1 | MCL: In situ
FL: LG/G1 |
In situ MCL: CD5−; cyclin D1+; CD23− FL: CD10+; BCL2+ |
NA | Not done | Not done | Not known | [5] |
|
| |||||||
| 2 | MCL: In situ
FL: LG/G1 |
In situ MCL: CD5+; cyclin D1+; CD23− FL: CD10+; BCL2+ |
t(11; 14) + t(14; 18) + |
Performed | IgH PCR FR1 FR3 JH | Clonally related | [6] |
|
| |||||||
| 3 | MCL: In situ
FL: LG/G1-2, in situ |
In situ MCL: CD5−; cyclin D1+; CD23− FL: CD10+; BCL2− In situ FL: CD10+; BCL2+ |
t(11; 14) + t(14; 18)+ |
Performed | IgH PCR FR2 D1–6 IgL PCR Vk/Kde | Clonally related | [7] |
|
| |||||||
| 4 | MCL: In situ
FL: Stage 4B |
In situ MCL: CD5−; cyclin D1+; CD23− FL: CD10+; BCL2+ |
NA | Not done | Not Done | Not known | [8] |
|
| |||||||
| 5 | MCL: In situ
FL: NA |
In situ MCL: CD5+; cyclin D1−; CD23− FL: CD10+; BCL2+ |
t(14; 18)(q32; q21) + t(11; 14)(q13; 32) + |
Performed | PCR for IgH | Clonally related | [9] |
|
| |||||||
| 6 | MCL: In situ
FL: NA |
In situ MCL: CD5+; cyclin D1+; CD23 NA FL: CD10+; BCL2+ |
t(11; 14) + t(14; 18) + |
Performed | PCR for IgH | Clonally related | [9] |